Axillary Botulinum Toxin Injection for the Treatment of Moderate to Severe Hyperhidrosis

被引:1
作者
Baghchechi, Mohsen [2 ]
Macknet, Kenneth D. [1 ]
Jacob, Sharon E. [1 ]
机构
[1] Loma Linda Univ, Dept Dermatol, 11370 Anderson St,Suite 2600, Loma Linda, CA 92354 USA
[2] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA
关键词
Hyperhidrosis; Botulinum Toxin; Injections;
D O I
10.1097/JDN.0000000000000594
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Primary focal hyperhidrosis can cause lifelong distress in everyday activities. Some patients cannot adequately decrease excessive perspiration with over-the-counter or prescription-strength antiperspirants. Oral glycopyrrolate is an anticholinergic medication that can decrease perspiration but may also lead to intolerable systemic side effects. Botulinum toxin injected into the axilla provides immediate symptomatic relief that lasts for approximately 6 months. Offering patients botulinum toxin as a second-line agent for treatment-resistant axillary hyperhidrosis can markedly improve quality of life with minimal side effects.
引用
收藏
页码:67 / 69
页数:3
相关论文
共 22 条
[1]   Use of oral glycopyrronium bromide in hyperhidrosis [J].
Bajaj, V. ;
Langtry, J. A. A. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (01) :118-121
[2]   Botulinum Toxin: Application, Safety, and Limitations [J].
Bigalke, Hans .
BOTULINUM NEUROTOXINS, 2013, 364 :307-317
[3]  
Cakan M, 2019, INT J MOL SCI
[4]   Pharmacology, toxicology and clinical safety of glycopyrrolate [J].
Chabicovsky, Monika ;
Winkler, Swantje ;
Soeberdt, Michael ;
Kilic, Ana ;
Masur, Clarissa ;
Abels, Christoph .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 370 :154-169
[5]   Treatment of Hyperhidrosis With Botulinum Toxin [J].
Doft, Melissa A. ;
Hardy, Krista L. ;
Ascherman, Jeffrey A. .
AESTHETIC SURGERY JOURNAL, 2012, 32 (02) :238-244
[6]   Hyperhidrosis: an update on prevalence and severity in the United States [J].
Doolittle, James ;
Walker, Patricia ;
Mills, Thomas ;
Thurston, Jane .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2016, 308 (10) :743-749
[7]   Comparing BotoxA® and XeominA® for axillar hyperhidrosis [J].
Dressler, Dirk .
JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (03) :317-319
[8]   Neutralizing Antibody and Botulinum Toxin Therapy: A Systematic Review and Meta-analysis [J].
Fabbri, Margherita ;
Leodori, Giorgio ;
Fernandes, Ricardo M. ;
Bhidayasiri, Roongroj ;
Jose Marti, Maria ;
Colosimo, Carlo ;
Ferreira, Joaquim J. .
NEUROTOXICITY RESEARCH, 2016, 29 (01) :105-117
[9]   Contraindications and complications with the use of botulinum toxin [J].
Klein, AW .
CLINICS IN DERMATOLOGY, 2004, 22 (01) :66-75
[10]   An epidemiological study of hyperhidrosis [J].
Lear, William ;
Kessler, Edward ;
Solish, Nowell ;
Glaser, Dee Anna .
DERMATOLOGIC SURGERY, 2007, 33 :S69-S75